Feeley I H, Healy E F, Noel J, Kiely P J, Murphy T M
RCSI, 123 St Stephens Green, Dublin, Ireland.
AMNCH, Tallaght, Dublin, Ireland.
Eur Spine J. 2017 Feb;26(2):336-344. doi: 10.1007/s00586-016-4437-0. Epub 2016 Feb 12.
Steroids in transforaminal epidural injections are widely used to ease radicular pain in both cervical and lumbar radiculopathy. Concerns have been articulated about the use of particulate steroids for this intervention, as a number of case reports have been published linking them with post procedural paralysis, possibly due to spinal ischaemia secondary to a steroid particulate embolism. Non-particulate, or soluble steroids, are mooted as an alternative; however, their effectiveness relative to particulate steroids has not been conclusively proven.
We review the evidence in the published literature regarding the efficacy of non-particulate steroids in epidural injections compared to particulate steroids, and synthesise it to gauge the qualitative outcomes from level one evidence (visual analogue scales, numerical pain scores and Oswestry Disability Index) from baseline to specified follow up.
The PRISMA guidelines were utilised for this review. An internet search was performed to collate the available literature from medical databases PubMed, EMBASE, Web of Science and the Cochrane library. We used a broad search term [epidural (and) steroid] to ensure a wide capture of articles. No limitations in terms of language or date of publication were implemented. The reference lists of articles included for full text review were searched for any additional primary or review publications.
Four online libraries were searched, with a combined total of 11,353 titles reviewed, not excluding duplicates. Post title abstract and full text review, nine articles were identified as suitable for inclusion for qualitative synthesis. Four of these were suitable for quantitative synthesis, with a total of 300 participants, 147 in the particulate group and 153 in the non-particulate group. Using a random effects model, the pooled standard mean difference of VAS score diminution was not significant between groups (0.31 in favour of particulates, 95 % CI -0.68 to 1.30). From our qualitative synthesis, there was a trend for greater improvement in pain scores within the particulate group. The type of steroid used did not appear to have an effect on the disability score given by patients.
Particulate steroids are not demonstrably better in relieving pain compared to their non-particulate counterparts. In view of the concerns over the safety profile of particulate steroids, it may be prudent to switch to non particulates, or at the very least the dangers and alternatives should be flagged with the patient group as part of a shared decision making process.
经椎间孔硬膜外注射类固醇广泛用于缓解颈、腰椎神经根病的神经根性疼痛。对于这种干预措施中使用颗粒状类固醇存在担忧,因为已有多篇病例报告将其与术后瘫痪联系起来,这可能是由于类固醇颗粒栓塞继发的脊髓缺血所致。非颗粒状或可溶性类固醇被提议作为替代方案;然而,它们相对于颗粒状类固醇的有效性尚未得到确凿证实。
我们回顾已发表文献中关于硬膜外注射非颗粒状类固醇与颗粒状类固醇疗效的证据,并对其进行综合分析,以评估从基线到指定随访期一级证据(视觉模拟量表、数字疼痛评分和奥斯威斯功能障碍指数)的定性结果。
本综述采用PRISMA指南。通过互联网搜索,从医学数据库PubMed、EMBASE、科学网和考克兰图书馆整理可用文献。我们使用宽泛的搜索词[硬膜外(和)类固醇]以确保广泛收录文章。未对语言或出版日期加以限制。对纳入全文综述的文章的参考文献列表进行搜索,以查找任何其他的原始或综述出版物。
搜索了四个在线图书馆,共审查了11353个标题,未排除重复项。经过标题摘要和全文审查,确定有九篇文章适合纳入定性综合分析。其中四篇适合进行定量综合分析,共有300名参与者,颗粒状组147名,非颗粒状组153名。使用随机效应模型,两组之间VAS评分降低的合并标准平均差异不显著(有利于颗粒状类固醇,差值为0.31,95%可信区间为-0.68至1.30)。从我们的定性综合分析来看,颗粒状组的疼痛评分有更大改善的趋势。所使用的类固醇类型似乎对患者给出的功能障碍评分没有影响。
与非颗粒状类固醇相比,颗粒状类固醇在缓解疼痛方面并无明显优势。鉴于对颗粒状类固醇安全性的担忧,改用非颗粒状类固醇可能较为谨慎,或者至少应将其风险和替代方案告知患者群体,作为共同决策过程的一部分。